Liver Diseases

Subtype terms (24)

More specific conditions that are subtypes of Liver Diseases in the MeSH hierarchy.

• alpha 1-Antitrypsin Deficiency

  36 drugs (14 approved, 22 experimental)

• Budd-Chiari Syndrome
• Chemical and Drug Induced Liver Injury

  44 drugs (34 approved, 10 experimental)

• Cholestasis, Intrahepatic

  11 drugs (8 approved, 3 experimental)

• Fatty Liver

  150 drugs (65 approved, 85 experimental)

• Focal Nodular Hyperplasia

  1 drug experimental

• Hepatic Infarction
• Hepatic Insufficiency

  74 drugs (47 approved, 27 experimental)

• Hepatic Veno-Occlusive Disease

  3 drugs approved

• Hepatitis

  51 drugs (33 approved, 18 experimental)

• Hepatolenticular Degeneration

  23 drugs (11 approved, 12 experimental)

• Hepatomegaly

  7 drugs (6 approved, 1 experimental)

• Hepatopulmonary Syndrome

  6 drugs approved

• Hepatorenal Syndrome

  12 drugs (9 approved, 3 experimental)

• Hypertension, Portal

  77 drugs (49 approved, 28 experimental)

• Liver Abscess

  6 drugs approved

• Liver Cirrhosis

  328 drugs (199 approved, 129 experimental)

• Liver Diseases, Alcoholic

  26 drugs (11 approved, 15 experimental)

• Liver Diseases, Parasitic
• Liver Neoplasms

  456 drugs (185 approved, 271 experimental)

• Peliosis Hepatis
• Porphyrias, Hepatic

  1 drug approved

• Tuberculosis, Hepatic
• Zellweger Syndrome

  7 drugs (6 approved, 1 experimental)

Drugs by status

Organizations